POSA50 Cost-Effectiveness Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Adolescent and Children Patients in Italy
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.195
https://www.valueinhealthjournal.com/article/S1098-3015(21)01990-2/fulltext
Title :
POSA50 Cost-Effectiveness Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Adolescent and Children Patients in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01990-2&doi=10.1016/j.jval.2021.11.195
First page :
Section Title :
Open access? :
No
Section Order :
10963